RxDoctor Payments Data

Elissa Castor

Surgical · Pittsburgh, PANPI 1689902561

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $18,650 of the $24,794 with a category attached, or 75.2%. Atricure, Inc. accounts for 92.2% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $23,132, more than ten times the $83 reported in 2021. Among surgical clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$24,794in general payments, 2019–2025

Across 62 payments — averaging $399.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Atricure, Inc.$23K
  • BTG International Inc.$2K
  • Abbott$266
  • Johnson & Johnson$52
  • Merck$18

What the payments were for

  • Consulting fees$18,65075%
  • Travel & lodging$3,92916%
  • Food & beverage$2,1979%
  • Education$180%

General payments by program year

21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Atricure, Inc.53$22,858
BTG International Inc.1$1,600
Abbott5$266
Johnson & Johnson2$52
Merck1$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$24,794 in reported general payments places this provider in the 95th percentile of 626 surgical providers in Pennsylvania.

See all surgical providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$3,868
Medicare patients
32
Services billed
33

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Losartan Potassium11$129
Mupirocin23$103

Paid to pharmacies, not to this prescriber.

Other surgical in Pittsburgh

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →